Sanquin
Not-for-profit national blood service that collects blood, plasma and platelets; performs donor screening and infectious-disease testing; operates fixed and mobile collection sites; supplies plasma to pharmaceutical processors for plasma‑derived medicines; and runs donor recruitment, appointment and donor‑management services across the Netherlands.
Industries
Nr. of Employees
Very Large (1000+)
Patents
Method for detecting CD4+CD25+glycoprotein A33(GPA33)high and/or CD4+CD127-GPA33high T cells
US-12180458-B2
View Details
Method for detecting CD4+CD25+glycoprotein A33(GPA33)high and/or CD4+CD127-GPA33high T cells
US-12180458-B2
View DetailsProducts
Collected plasma supplied for plasma‑derived medicines
Collected human plasma provided to pharmaceutical processors that manufacture plasma‑derived medicinal products for patients with immunological and coagulation disorders.
Collected plasma supplied for plasma‑derived medicines
Collected human plasma provided to pharmaceutical processors that manufacture plasma‑derived medicinal products for patients with immunological and coagulation disorders.
Services
Recruitment, medical screening, collection and testing of whole blood donations at fixed and mobile locations; includes first‑visit medical checks and donor follow‑up.
Apheresis collection of plasma for use as raw material by commercial processors that manufacture plasma‑derived medicinal products.
Apheresis collection of platelets, HLA/tissue typing for matching, and rapid call‑out procedures for patient‑specific transfusion needs.
Deployment of mobile collection trailers equipped for multiple donors, screening rooms and climate control to provide temporary local donation sites.
Online donor registration, appointment booking, donor profile management (self‑service portal) and automated call/notification systems.
Recruitment, medical screening, collection and testing of whole blood donations at fixed and mobile locations; includes first‑visit medical checks and donor follow‑up.
Apheresis collection of plasma for use as raw material by commercial processors that manufacture plasma‑derived medicinal products.
Apheresis collection of platelets, HLA/tissue typing for matching, and rapid call‑out procedures for patient‑specific transfusion needs.
Deployment of mobile collection trailers equipped for multiple donors, screening rooms and climate control to provide temporary local donation sites.
Online donor registration, appointment booking, donor profile management (self‑service portal) and automated call/notification systems.
Expertise Areas
- Blood collection and transfusion services
- Apheresis (plasmapheresis and plateletpheresis)
- Donor recruitment and retention
- Infectious‑disease screening and blood testing
Key Technologies
- Apheresis / plasmapheresis
- Blood component separation
- Serological and infectious‑disease testing
- Blood group typing
News & Updates
Regulatory/eligibility update: from 1 October 2024 people who previously received a blood transfusion may, in some cases, again be eligible to donate; guidance and screening procedures updated accordingly.
Regulatory/eligibility update: from 1 October 2024 people who previously received a blood transfusion may, in some cases, again be eligible to donate; guidance and screening procedures updated accordingly.